NBSC Names Kennedy to Board of Directors

COLUMBIA, SC – NBSC, a division of Synovus Bank, announces the appointment of Lou Kennedy to its South Carolina Board of Directors.

“We are delighted that Lou has joined our board. She is a proven leader in our state and we are honored to have her on our board,” said Chuck Garnett, President and Chief Executive Officer of NBSC.

Kennedy is President, Chief Executive Officer and Owner of Nephron Pharmaceuticals Corporation. Headquartered in Orlando, Florida, Nephron Pharmaceuticals recently opened a manufacturing facility in West Columbia, South Carolina.

A graduate of the University of South Carolina, Kennedy helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy. She serves on the Palmetto Conservation Foundation Board, the Garnet Way Campaign and the Central Florida Cystic Fibrosis Foundation Advisory Board. In addition, she holds the Pharmacy Chair of the USC Carolina’s Promise Campaign.

NBSC is a division of Synovus Bank and currently serves 26 communities in South Carolina from 42 locations. For more than 100 years, NBSC has focused on relationship banking and remains dedicated to the communities it serves. Together with affiliates of Synovus Bank, NBSC offers diverse lines of business and personal financial services including Business Banking, Investment Services, and Mortgage Lending.  For more information, visit www.bankNBSC.com.

Synovus Bank is a Georgia-chartered, FDIC-insured bank. Synovus Bank, together with its affiliates, provides commercial and retail banking, investment, and mortgage services to customers through 28 locally branded divisions, 271 branches, and 358 ATMs in Georgia, Alabama, South Carolina, Florida, and Tennessee.  See Synovus Bank on the web at synovus.com, on twitter @synovusbank, and LinkedIn. Equal Housing Lender.